Find Clinical Trials
Clinical acceptability study of micronized purified flavonoid fraction 1000 mg, one tablet per day compared to micronized purified flavonoid fraction 500 mg, two tablets daily after 8 weeks of treatment in patients suffering from symptomatic chronic venous disease (CVD): an international, multicenter, double-blind, randomized, parallel group study
Servier Protocol Code:
CL3-05682-107
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- venous disease
- MICRONISED PURIFIED FLAVONOID FRACTION
- S005682
Other study id numbers
Other identification numbers the study may be known by.
- CL3-05682-107